The Cook Perspective

A rare disease drug's EU approval is revoked over 'misleading' data, impacting patients and signaling a new era of strict regulatory scrutiny for pharma giants.

Peterborough Regional Health Centre pioneers a new era of safety with AI-driven screening, aiming to protect without creating barriers. Is this the future?

While Oxfam Canada preaches gender equality and economic justice worldwide, its own workers are on the picket line fighting for domestic violence leave and fair pay.

The iconic spicy snack is ditching artificial colors, but this isn't just a recipe change. It's a calculated response to a perfect storm of consumer demand, regulatory pressure, and a global corporate mandate.

A medical imaging firm and a South African gas project merge in a bold, complex deal. Will this unlikely union unlock critical helium supplies or just dilute value?

As MAPS announces its 2027 summit, the psychedelic field grapples with a critical question: can its visionary promise survive the harsh pressures of reality?

MN8 Energy’s award-winning deal isn’t just a trophy; it’s a sophisticated financial blueprint poised to reshape how we fund the green energy transition.

Promising 3-year survival data for a novel immunotherapy combo offers new hope for patients with MSS colorectal cancer, a notoriously difficult disease.

KBR appoints seasoned leaders for its $5B+ Mission Technology Solutions spin-off, creating a new force in space and defense while sharpening its own focus on sustainability.

While NANO Nuclear pushes into emerging global markets, a sudden leadership change puts its CEO in direct control of its flagship microreactor project.

ASUS's new ExpertCenter Pro ET900N G3 brings supercomputer power to the office, challenging the cloud's dominance and heralding a new era of local AI.

As Impact Capital Managers brings in heavy-hitters to its board, it’s a clear sign the $80B sector is moving from niche to mainstream. Here’s why.

Northern Trust's Civic 50 award isn't just a trophy. It reveals a strategic blueprint for social impact, linking employee engagement and millions in aid.

The classic virtual pet's arrival in Fortnite isn't just a nostalgic gimmick; it's a calculated move in a high-stakes strategy to reclaim cultural relevance.

As AI and human agents create disjointed customer experiences, Zenarate's new Evolve platform promises a unified approach to training, managing, and improving both.

BOTOX® Cosmetic is investing millions in women entrepreneurs. Is it smart philanthropy, or a brilliant new blueprint for brand building and corporate strategy?

Amid soaring premiums and regulatory fire, a new data intelligence suite promises to transform the UK's archaic motor claims process from chaos to clarity.

As AI moves from experiment to enterprise necessity, ABBYY's growing developer conference in India signals a critical shift toward trusted, standardized AI.

In just three years, BELLUSTAR TOKYO has become a luxury titan. We deconstruct the strategy that blends urban grit with serene opulence to dominate the market.

A new generation of ultra-precise syringes is quietly enabling the future of gene therapy and neuroscience. Here’s why this small innovation is a giant leap.